PegBio Reports Stable Share Capital in May 2026 and Affirms Public Float Compliance

Bulletin Express06-03

PegBio Co., Ltd. released its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 May 2026, confirming that there were no changes to its share capital structure during the month.

Registered Capital Structure • H-share tranche: 284.30 million ordinary shares at a par value of RMB 1.00 each, all listed on the Hong Kong Stock Exchange. • Unlisted domestic tranche: 106.79 million ordinary shares at the same par value. • Combined registered share capital: 391.09 million shares, unchanged from the preceding month.

Issued Shares and Public Float • Issued H-shares stood at 284.30 million, with zero treasury shares, indicating no share issuance, cancellation, or repurchase activities in May. • PegBio confirmed that its public float comfortably meets the Main Board’s minimum 25 % requirement, based on publicly available information.

Capital Instruments and Corporate Actions • The company reported no outstanding or new share options, warrants, convertibles, or other equity-linked agreements. • No Hong Kong Depositary Receipts are in circulation.

Administrative Details The filing, dated 3 June 2026, was signed by Joint Company Secretary Huang Yifeng, reaffirming compliance with all relevant Hong Kong Listing Rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1121378543?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121378543","market":"us","top_or_hot":-1,"title":"PegBio Reports Stable Share Capital in May 2026 and Affirms Public Float Compliance","media":"Bulletin Express","content":"<p>PegBio Co., Ltd. released its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 May 2026, confirming that there were no changes to its share capital structure during the month.</p>\n<p>Registered Capital Structure  \n• H-share tranche: 284.30 million ordinary shares at a par value of RMB 1.00 each, all listed on the Hong Kong Stock Exchange.  \n• Unlisted domestic tranche: 106.79 million ordinary shares at the same par value.  \n• Combined registered share capital: 391.09 million shares, unchanged from the preceding month.</p>\n<p>Issued Shares and Public Float  \n• Issued H-shares stood at 284.30 million, with zero treasury shares, indicating no share issuance, cancellation, or repurchase activities in May.  \n• PegBio confirmed that its public float comfortably meets the Main Board’s minimum 25 % requirement, based on publicly available information.</p>\n<p>Capital Instruments and Corporate Actions  \n• The company reported no outstanding or new share options, warrants, convertibles, or other equity-linked agreements.  \n• No Hong Kong Depositary Receipts are in circulation.</p>\n<p>Administrative Details  \nThe filing, dated 3 June 2026, was signed by Joint Company Secretary Huang Yifeng, reaffirming compliance with all relevant Hong Kong Listing Rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PegBio Reports Stable Share Capital in May 2026 and Affirms Public Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPegBio Reports Stable Share Capital in May 2026 and Affirms Public Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PegBio Co., Ltd. released its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 May 2026, confirming that there were no changes to its share capital structure during the month.</p>\n<p>Registered Capital Structure  \n• H-share tranche: 284.30 million ordinary shares at a par value of RMB 1.00 each, all listed on the Hong Kong Stock Exchange.  \n• Unlisted domestic tranche: 106.79 million ordinary shares at the same par value.  \n• Combined registered share capital: 391.09 million shares, unchanged from the preceding month.</p>\n<p>Issued Shares and Public Float  \n• Issued H-shares stood at 284.30 million, with zero treasury shares, indicating no share issuance, cancellation, or repurchase activities in May.  \n• PegBio confirmed that its public float comfortably meets the Main Board’s minimum 25 % requirement, based on publicly available information.</p>\n<p>Capital Instruments and Corporate Actions  \n• The company reported no outstanding or new share options, warrants, convertibles, or other equity-linked agreements.  \n• No Hong Kong Depositary Receipts are in circulation.</p>\n<p>Administrative Details  \nThe filing, dated 3 June 2026, was signed by Joint Company Secretary Huang Yifeng, reaffirming compliance with all relevant Hong Kong Listing Rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02565","symbol_name":"派格生物医药-B","start_time":0,"source_url":"","article_id":"1121378543","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121378543","pubTimestamp":1780477526,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"PegBio Co., Ltd. released its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 May 2026, confirming that there were no changes to its share capital structure during...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02565":"派格生物医药-B"},"translate_title":"PegBio报告2026年5月股本稳定并确认公众持股量合规性","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02565":1},"content_text":"PegBio Co., Ltd. released its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 May 2026, confirming that there were no changes to its share capital structure during the month.\nRegistered Capital Structure  \n• H-share tranche: 284.30 million ordinary shares at a par value of RMB 1.00 each, all listed on the Hong Kong Stock Exchange.  \n• Unlisted domestic tranche: 106.79 million ordinary shares at the same par value.  \n• Combined registered share capital: 391.09 million shares, unchanged from the preceding month.\nIssued Shares and Public Float  \n• Issued H-shares stood at 284.30 million, with zero treasury shares, indicating no share issuance, cancellation, or repurchase activities in May.  \n• PegBio confirmed that its public float comfortably meets the Main Board’s minimum 25 % requirement, based on publicly available information.\nCapital Instruments and Corporate Actions  \n• The company reported no outstanding or new share options, warrants, convertibles, or other equity-linked agreements.  \n• No Hong Kong Depositary Receipts are in circulation.\nAdministrative Details  \nThe filing, dated 3 June 2026, was signed by Joint Company Secretary Huang Yifeng, reaffirming compliance with all relevant Hong Kong Listing Rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1121378543","isCrawlerRequest":true}